Amanta Healthcare Share Price in Focus; Promoter Group Member Buys 16,200 Shares Via Open Market

Amanta Healthcare Limited has disclosed an open-market purchase of equity shares by a promoter group member under SEBI's Insider Trading Regulations. 

The transaction was reported through a regulatory filing submitted to stock exchanges on June 22, 2026.  

Promoter Group Member Acquires Additional Shares 

According to the disclosure, Jitendrakumar Jashbhai Patel, a member of the promoter group, purchased 16,200 equity shares of Amanta Healthcare through an open-market transaction.  

Transaction Value Stands At ₹24.30 Lakh 

The shares were acquired for a total consideration of ₹24,29,680 through a market purchase executed on the National Stock Exchange (NSE).  

Shareholding Increases to 9.02% 

Following the acquisition, Jitendrakumar Jashbhai Patel's shareholding increased from 34,85,838 equity shares, representing 8.98% of the company, to 35,02,038 equity shares, or 9.02% of the total shareholding.  

Disclosure Made Under Insider Trading Regulations 

The transaction was disclosed under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. 

The filing relates to continual disclosures required for transactions undertaken by promoters, promoter group members, designated persons, and other specified entities.  

Read More: Urban Company Share Price Jumps 7%; Stock Rebounds 45% From March Low! 

Amanta Healthcare Share Price Performance 

As of  22 June 2026 Amanta Healthcare share price was closed at ₹160.50 per share, reflecting a surge of 2.63% from the previous trading session. 

Conclusion 

Amanta Healthcare disclosed that promoter group member Jitendrakumar Jashbhai Patel purchased 16,200 equity shares through an open-market transaction worth about ₹24.30 lakh. The acquisition increased his stake in the company from 8.98% to 9.02%.  

Want to read stock market updates in Hindi? Angel One News gives comprehensive share market news in Hindi. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.